Limitations and uncertainty around telehealth reimbursement have always been an impediment to adoption. During the COVID-19 emergency, that burden was eased somewhat, but now the new normal is starting to take shape. What barriers still remain to telehealth reimbursement, and how might they be overcome? To answer that question, host Jonah Comstock and Healthcare Finance News Managing Editor Susan Morse welcome McKinsey & Company Partners Oleg Bestsennyy and Gunjan Khanna.
This episode is brought to you by BlueJeans.
More about this episode:
Report shows 'vast improvement' in state telehealth reimbursement policies
COVID-19 may permanently alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurer concerns of overutilization
CMS will reimburse for 11 new telehealth services during the public health emergency
Telehealth: A quarter-trillion-dollar post-COVID-19 reality? (McKinsey)
COVID-19 Consumer Healthcare Insights: What 2021 may hold (McKinsey)
How COVID-19 has changed the way US consumers think about healthcare (McKinsey)